X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 147,218 | 60,493 | 99,216 | 131,581 | 136,428 |
| Marketable Securities | 21,536 | 20,376 | 15,000 | 10,102 | 4,881 |
| Receivables | 854 | 702 | 562 | 393 | 820 |
| Inventories | 831 | N/A | N/A | N/A | N/A |
| TOTAL | $175,416 | $87,333 | $122,076 | $147,872 | $147,649 |
| Non-Current Assets | |||||
| PPE Net | 808 | 742 | 745 | 772 | 868 |
| Intangibles | 27,726 | 17,351 | 17,351 | 17,351 | 17,351 |
| Other Non-Current Assets | 6,661 | 6,756 | 7,086 | 7,298 | 7,531 |
| TOTAL | $35,195 | $24,849 | $25,182 | $25,421 | $25,750 |
| Total Assets | $210,611 | $112,182 | $147,258 | $173,293 | $173,399 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 0 | 764 |
| Accounts payable and accrued liabilities | 7,986 | 8,935 | 8,947 | 8,132 | 5,108 |
| Accrued Expenses | 19,744 | 13,473 | 12,816 | 16,184 | 15,231 |
| TOTAL | $28,902 | $23,541 | $22,862 | $25,432 | $22,251 |
| Non-Current Liabilities | |||||
| Long Term Debt | 75,030 | 54,824 | 54,570 | 54,322 | 31,836 |
| Other Non-Current Liabilities | 12,228 | 32,781 | 18,727 | 25,945 | 51,777 |
| TOTAL | $87,258 | $87,605 | $73,297 | $80,267 | $83,613 |
| Total Liabilities | $116,160 | $111,146 | $96,159 | $105,699 | $105,864 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,611 | 5,592 | 5,592 | 5,571 | 5,475 |
| Common Shares | 168 | 168 | 167 | 165 | 164 |
| Retained earnings | -438,838 | -529,671 | -477,905 | -458,775 | -456,470 |
| Other shareholders' equity | -159 | -155 | -119 | -119 | -119 |
| TOTAL | $94,451 | $1,036 | $51,099 | $67,594 | $67,535 |
| Total Liabilities And Equity | $210,611 | $112,182 | $147,258 | $173,293 | $173,399 |